Atlas Trials

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

Clinical trial NCT04849000 · COMPLETED

Trial details

NCT number
NCT04849000
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary HypercholesterolemiaMixed Hyperlipemia
Start date
2021-04-23
Primary completion
2022-06-21
Enrollment
709

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.